This is a working overview of animal model, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-26 and is reviewed periodically as new material appears.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Standard practice for the solid form is storage at minus twenty degrees Celsius or colder, kept dry and away from light. Containers are usually sealed with a desiccant to limit moisture uptake. Reconstituted solutions are typically held at two to eight degrees Celsius and used within a short window, because potency can decline over days to weeks depending on the buffer and concentration. Freezing an already dissolved sample may help, though repeated thawing is discouraged. Specific shelf-life claims vary between suppliers and are rarely supported by published stability studies.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
| Property | Value | Notes |
|---|---|---|
| Typical subjects | Rats and mice | Animal models |
| Common routes | Injection and oral | Route varies by study |
| Reported dose range | Microgram to milligram per kg | Not standardized across work |
| Frequent endpoints | Tissue repair, angiogenesis | Marker-dependent |
| Human evidence | Limited | Mostly small or preliminary studies |
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
Two conserved cysteines coordinate one Fe ion while the other Fe ion is coordinated by two conserved histidines. The 2Fe-2S cluster is bound in the highly conserved C-terminal region of the Rieske subunit.
== History == The method of thermospray ionization was first introduced by a patent evidenced as early as 1983, and described in further detail by a patent published on March 8, 1988. Inventors Marvin L. Vestal and Calvin R. Blakley proposed an ion vapor source for mass spectrometry of liquids under a US Grant from the Department of Health, Education, and Welfare. The proposed method detailed a coupling device between liquid chromatographic columns and various methods of detection for gaseous samples; like mass spectrometry, electron capture, atomic adsorption, etc. Four different representations of the thermospray vaporizer were presented in the 1988 patent – UA4730111A. Nonvolatile, ionic, and thermally labile solutes were investigated with the various control systems on the vaporizers to achieve partial vaporization.
=== Multicolour Labelling === Since EosFP can be used in fusion constructs while maintaining functionality of the protein of interest, it is a popular choice for multi-colour labelling studies. In a dual-colour labelling experiment to map the stages of mitosis, HEK293 cells were first stably transfected with tubulin-binding protein cDNA fused to EGFP for visualization of the spindle apparatus. Then, transient transfection of recombination signal-binding protein (RBP) fused to d2EosFP was used to visualize the beginning of mitosis. Photoconversion was completed by fluorescent microscopy and highlighted the separation between two sets of chromosomes during anaphase, telophase and cytokinesis.
== Education and early career == Cremer's father moved to a new position in Berlin and Cremer had trouble adjusting to the new Prussian school system. Cremer graduated high school in Berlin in 1921 and matriculated to the University of Berlin to study chemistry. At the University of Berlin, she attended lectures by Fritz Haber, Walther Nernst, Max Planck, Max von Laue, and Albert Einstein. Cremer received her Ph.D. magna cum laude six years later in 1927 under Max Bodenstein. Her dissertation was on the kinetics of the hydrogen-chlorine reaction. The paper was published under her name only because it concluded that the hydrogen-chlorine reaction was a chain reaction, which was still considered an extremely original concept for that time. Because of this paper and her work on kinetics, the future Nobel Laureate for the study of kinetics, Nikolay Semyonov invited her to Leningrad to work. She refused and remained in Germany to work at the Kaiser Wilhelm Institute for Physical Chemistry and Electrochemistry with Karl Friedrich Bonhoeffer on the quantum theoretical problems of photochemistry. Cremer studied the breakdown of alcohols using oxide catalysts on scholarship at the University of Freiburg with George de Hevesy for a brief time. Cremer returned to Berlin to work with Michael Polanyi at Haber's Institut, where they investigated the conversion of hydrogen and ortho-hydrogen in one spin state to para-hydrogen. She remained there until 1933 when the Nazi party came to power in Germany and the institute was dissolved for its reputation as anti-Nazi.
Sources: en.wikipedia.org
Refers to any of the FDA procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials. (NLM) Expanded access trial
Cultivation is successful in climates with hot summers, with optimum growing conditions in mean temperatures of 20 to 30 °C (70 to 85 °F); temperatures of below 20 °C (70 °F) and over 40 °C (105 °F) stunt growth significantly. They can grow in a wide range of soils, with optimum growth in moist alluvial soils with good organic content. Soybeans, like most legumes, perform nitrogen fixation by establishing a symbiotic relationship with the bacterium Bradyrhizobium japonicum (syn. Rhizobium japonicum; Jordan 1982). This ability to fix nitrogen allows farmers to reduce nitrogen fertilizer use and increase yields when growing other crops in rotation with soy. There may be some trade-offs, however, in the long-term abundance of organic material in soils where soy and other crops (for example, corn) are grown in rotation. For best results, though, an inoculum of the correct strain of bacteria should be mixed with the soybean (or any legume) seed before planting. Modern crop cultivars generally reach a height of around 1 m (3 ft), and take 80–120 days from sowing to harvesting.
atomic number (Z) Also proton number. The number of protons found in the nucleus of an atom of a given chemical element. It is identical to the charge number of the nucleus and is used in the periodic table to uniquely identify each chemical element.
Sources: en.wikipedia.org
=== Synthesis and release === The corpus luteum produces the 6-kDa peptide hormone relaxin. Prolactin and insulin-like growth factor binding protein are two examples of the hormones and growth factors that relaxin can stimulate the secretion of. Preprorelaxin is the collective term for the signal peptide, B chain, C peptide, and A chain found in the coding area of human relaxin genes. The signal peptide is cleaved to produce prorelaxin. Prohormone convertases, such as prohormone convertase-1 and prohormone convertase-2, can convert prorelaxin to mature relaxin.
=== Radiation processes === Some proponents for the authenticity of the Shroud of Turin have argued that the image on the shroud was created by some form of radiation emission at the "moment of resurrection". However, the STURP member Alan Adler has stated that this theory is not generally accepted as scientific, given that it runs counter to the laws of physics, while agreeing that the darkening of the fabric could be produced by exposure to light (and predicting that despite the fact that the Shroud is normally stored in darkness and rarely displayed, it will eventually become darker in the future). Raymond Rogers also criticized the theory, saying: "It is clear that a corona discharge (plasma) in air will cause easily observable changes in a linen sample. No such effects can be observed in image fibers from the Shroud of Turin. Corona discharges or plasmas made no contribution to image formation." Even if ultraviolet radiation were proven to have formed the image, it cannot be proven that it was not natural, that of the sun, applied to the prepared cloth unevenly to create the image. Others have hypothesized that an earthquake after Jesus’ death could have released a burst of neutrons that irradiated the shroud and changed some of the nuclei to different isotopes by neutron capture.
Vitamin B12 is included in multivitamin pills; in some countries grain-based foods, such as bread and pasta, are fortified with B12. In the US, non-prescription products can be purchased providing up to 1,000 μg each, and it is a common ingredient in energy drinks and energy shots, usually at many times the recommended dietary allowance of B12. The vitamin can also be supplied on prescription and delivered via injection or other means. When used in supplementation, all of the vitamin B12 vitamers have been argued to be beneficial, with there not being clear evidence that any are relatively more or less effective. The amount of cyanide in cyanocobalamin is generally not considered a health risk, since even in a 1,000 μg dose, the 20 μg of cyanide it contains is less than the daily consumption of cyanide from food.
Sources: en.wikipedia.org
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.
Frequently measured outcomes include wound healing, blood vessel growth, and tissue repair markers. Some work examines gastrointestinal protection. The choice of endpoint depends on the model used.
Different routes of administration and different animal models require different amounts. Studies also use varied timelines and measurement methods. This variation makes it difficult to combine results into a single standardized figure.
Reversed-phase HPLC separates the sample into peaks, and the main peak is expressed as a percentage of total peak area. Mass spectrometry is then used to confirm that the molecular mass matches the expected value.